Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Completes Pre-Clinical Studies, Progresses Two Drug Candidates
Cybin has completed more than 20 pre-clinical studies in record time. Company is advancing two new therapeutic candidates with enhanced,…
Cybin has completed more than 20 pre-clinical studies in record time. Company is advancing two new therapeutic candidates with enhanced,…
Healthy Extracts Inc. recently declared its 2020 Q4 results, with revenue growth at 71% over the previous year The company’s…
Asia Broadband (OTC: AABB), a resource company focused on the production, supply and sale of precious and base metals, today…
PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of its new YouTube series entitled "Taste…
With pandemic-imposed restrictions in place, more artists and fans turn towards livestreaming options such as Fan Pass Providing a safe…
Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a leading provider of virtual and augmented reality (“AR”) experience technologies…
Red White & Bloom Brands (CSE: RWB) (OTC: RWBYF) today reported plans to increase cultivation capacity upon closing of the…
Perpetual Industries (OTC: PRPI), an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the…
AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases,…
Satsuma Pharmaceuticals (NASDAQ: STSA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report…